Results 171 to 180 of about 7,334 (206)
Some of the next articles are maybe not open access.
Annals of Internal Medicine, 1981
Minoxidil is an orally active vasodilator for treatment of severe hypertension. In combination with diuretics and beta-adrenergic blocking agents, it is effective treatment for more than 80% of patients whose blood pressure has been inadequately controlled with combinations of other been inadequately controlled with combinations of other ...
S L, Linas, A S, Nies
openaire +2 more sources
Minoxidil is an orally active vasodilator for treatment of severe hypertension. In combination with diuretics and beta-adrenergic blocking agents, it is effective treatment for more than 80% of patients whose blood pressure has been inadequately controlled with combinations of other been inadequately controlled with combinations of other ...
S L, Linas, A S, Nies
openaire +2 more sources
Annals of Internal Medicine, 1990
Excerpt To the Editors:Topical minoxidil has been commercially available since 1987 for the treatment of baldness. Except for contact dermatitis, it is considered free of adverse reactions (1).
R Colamarino, J J Dubost, B Sauvezie
openaire +3 more sources
Excerpt To the Editors:Topical minoxidil has been commercially available since 1987 for the treatment of baldness. Except for contact dermatitis, it is considered free of adverse reactions (1).
R Colamarino, J J Dubost, B Sauvezie
openaire +3 more sources
Minoxidil in severe hypertension
European Journal of Clinical Pharmacology, 1978Minoxidil is a potent anti-hypertensive drug which acts on the peripheral arteriolar smooth muscle. It was administered to 14 patients with severe hypertension where standard therapy failed to control the blood pressure. The mean initial blood pressure was 209/129 when receiving treatment.
Pierre Larochelle+3 more
openaire +6 more sources
American Journal of Health-System Pharmacy, 1980
The chemistry, pharmacokinetics, mechanism of action, clinical studies, adverse effects, toxicology, indications, contraindications, drug interactions, and dosing of minoxidil, a recently approved antihypertensive agent, are reviewed. Minoxidil is an orally effective vasodilator that selectively relaxes peripheral arteriolar smooth muscle, Reflex ...
Delwyn D. Miller, David W. Love
openaire +3 more sources
The chemistry, pharmacokinetics, mechanism of action, clinical studies, adverse effects, toxicology, indications, contraindications, drug interactions, and dosing of minoxidil, a recently approved antihypertensive agent, are reviewed. Minoxidil is an orally effective vasodilator that selectively relaxes peripheral arteriolar smooth muscle, Reflex ...
Delwyn D. Miller, David W. Love
openaire +3 more sources
Hypertrichosis due to minoxidil
British Journal of Dermatology, 1979A case of hypertrichosis due to the hypotensive drug minoxidil is described. A review of the literature suggests that this complication appears in nearly all patients treated with this drug. The mechanism is unknown, but the similarity to the cases of hypertrichosis due to diazoxide, another potent vasodilator, suggests that increased cutaneous blood ...
A. Marshall, J.L. Burton
openaire +3 more sources
Thrombocytopenia and Minoxidil
Annals of Internal Medicine, 1980Excerpt To the editor: Recently we cared for a patient who developed mild thrombocytopenia related in time to the ingestion of minoxidil (Loniten; Upjohn Company, Kalamazoo, Michigan), a potent ora...
Steven J. Peitzman, Clarence Martin
openaire +2 more sources
Dermatologic Clinics, 1987
Topical minoxidil has shown some promise for the treatment of male-pattern alopecia and alopecia areata. Clinical trials suggest that careful patient selection and appropriate drug formulation are both important factors to maximize efficacy. Side effects attributable to topical minoxidil appear to consist almost entirely of cutaneous reactions in ...
openaire +2 more sources
Topical minoxidil has shown some promise for the treatment of male-pattern alopecia and alopecia areata. Clinical trials suggest that careful patient selection and appropriate drug formulation are both important factors to maximize efficacy. Side effects attributable to topical minoxidil appear to consist almost entirely of cutaneous reactions in ...
openaire +2 more sources
Percutaneous Absorption of Minoxidil
Archives of Dermatology, 1986To the Editor.— In the February issue of theArchives, Franz 1 described the percutaneous absorption of minoxidil labeled with carbon 14 following the application to the scalp in 12 healthy adult male subjects. Based on the amount of radioactivity excreted in the urine and feces, he concluded that only a small fraction of the total dose of applied ...
Rokea el-Azhary, Leonard Harry Goldberg
openaire +3 more sources